Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

4.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.4K
Tumor Progression02:07

Tumor Progression

6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

12.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

B7-H3 membranous expression correlates with histological grading in a two-center cohort of 133 pre-treatment bone and soft tissue sarcoma samples.

BMC cancer·2026
Same author

Darizmetinib (HRX215): A Promising 1st-in-Class Liver Regenerating Drug in Phase 1b/2a Clinical Development, Targeting the Stress Signaling Protein Kinase MKK4.

Journal of medicinal chemistry·2026
Same author

Author Correction: Titration of RAS alters senescent state and influences tumour initiation.

Nature·2026
Same author

Author Correction: A complex secretory program orchestrated by the inflammasome controls paracrine senescence.

Nature cell biology·2026
Same author

When AI joins the table: evaluating large language model performance in soft tissue sarcoma tumor board decisions.

Journal of cancer research and clinical oncology·2026
Same author

Primary Renal Neuroendocrine Tumor: Diagnostic Challenges in a Rare Entity-A Case Report.

Current oncology (Toronto, Ont.)·2026
Same journal

Explainable incremental-value analysis of apparent diffusion coefficient and arterial spin labeling radiomics for ATRX status prediction in glioblastoma.

Frontiers in oncology·2026
Same journal

Study-level factors associated with hematoma after ultrasound-guided vacuum-assisted breast lesion excision: a systematic review and meta-analysis using a T-P-B framework.

Frontiers in oncology·2026
Same journal

Feasibility and strategy analysis of radiotherapy consolidation following immunotherapy for stage IV esophageal squamous cell carcinoma.

Frontiers in oncology·2026
Same journal

Anastomosing hemangioma of the kidney: a case report.

Frontiers in oncology·2026
Same journal

Machine learning-based prediction of prolonged air leak after uniportal video-assisted thoracic surgery segmentectomy.

Frontiers in oncology·2026
Same journal

Past present and future of radiosensitization in cervical cancer.

Frontiers in oncology·2026
See all related articles

Related Experiment Video

Updated: Sep 1, 2025

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

10.7K

NUT Carcinoma-An Underdiagnosed Malignancy.

Ulrich M Lauer1,2,3, Martina Hinterleitner1,2,3, Marius Horger2,4

  • 1Medical Oncology and Pneumology, Internal Medicine VIII, University Hospital Tübingen, Tübingen, Germany.

Frontiers in Oncology
|August 12, 2022
PubMed
Summary
This summary is machine-generated.

NUT carcinoma (NC) is a rare, aggressive cancer often underdiagnosed. This review highlights its characteristics, diagnosis, and the potential of BET inhibitors as novel therapies for this challenging malignancy.

Keywords:
BET inhibitorBRD4NUT carcinomaNUT rearrangementNUTM1

More Related Videos

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

1.9K
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

901

Related Experiment Videos

Last Updated: Sep 1, 2025

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

10.7K
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

1.9K
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

901

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • NUT carcinoma (NC) is a rare and aggressive cancer with poor prognosis.
  • It primarily affects midline structures but can occur elsewhere, often being underdiagnosed due to low awareness.

Purpose of the Study:

  • To raise awareness of NUT carcinoma, an underdiagnosed malignancy.
  • To provide information on diagnostic criteria and potential novel therapies.

Main Methods:

  • Review of existing literature on NUT carcinoma.
  • Discussion of diagnostic methods, including immunohistochemistry for NUTM1.
  • Exploration of the molecular pathogenesis involving NUTM1 fusions and BET proteins.

Main Results:

  • NC is characterized by NUTM1 gene fusions, leading to dysregulated gene expression via BET proteins.
  • Histologic features can suggest NC, warranting NUTM1 testing.
  • BET inhibitors are emerging as promising therapeutic agents.

Conclusions:

  • Increased awareness and routine testing for NUTM1 are crucial for accurate NC diagnosis.
  • Novel therapies targeting the BET pathway offer new hope for patients with this aggressive cancer.